US Stock MarketDetailed Quotes

ABUS Arbutus Biopharma

Watchlist
  • 2.710
  • +0.030+1.12%
Close May 3 16:00 ET
  • 2.700
  • -0.010-0.37%
Post 17:39 ET
511.42MMarket Cap-6159P/E (TTM)

Arbutus Biopharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
-53.51%18.14M
-65.65%2.15M
-21.74%4.66M
-67.34%4.65M
-46.85%6.69M
255.11%39.02M
94.79%6.25M
78.20%5.95M
511.46%14.24M
495.41%12.58M
Operating revenue
-53.51%18.14M
-65.65%2.15M
-21.74%4.66M
-67.34%4.65M
-46.85%6.69M
255.11%39.02M
94.79%6.25M
78.20%5.95M
511.46%14.24M
495.41%12.58M
Cost of revenue
Gross profit
Operating expense
-5.93%96.18M
-16.67%22.67M
10.46%26.01M
-15.88%23.67M
2.03%23.83M
23.72%102.24M
14.23%27.2M
12.71%23.55M
38.79%28.14M
32.24%23.35M
Selling and administrative expenses
26.02%22.48M
20.05%5.1M
67.25%5.84M
15.00%5.98M
13.49%5.55M
4.07%17.83M
-7.57%4.25M
-16.50%3.49M
16.12%5.2M
26.15%4.89M
-General and administrative expense
26.02%22.48M
20.05%5.1M
67.25%5.84M
15.00%5.98M
13.49%5.55M
4.07%17.83M
-7.57%4.25M
-16.50%3.49M
16.12%5.2M
26.15%4.89M
Research and development costs
-12.69%73.7M
-23.47%17.56M
0.57%20.17M
-22.88%17.69M
-1.01%18.28M
28.86%84.41M
19.45%22.95M
20.03%20.06M
45.21%22.94M
33.96%18.46M
Operating profit
-23.43%-78.03M
2.07%-20.52M
-21.35%-21.35M
-36.83%-19.02M
-59.10%-17.14M
11.76%-63.22M
-1.70%-20.95M
-0.25%-17.6M
22.55%-13.9M
30.71%-10.77M
Net non-operating interest income expense
1,022.10%5.23M
124.13%1.42M
446.42%1.45M
1,600.00%1.29M
408.36%1.07M
117.07%466K
219.62%634K
136.05%265K
88.25%-86K
52.66%-347K
Non-operating interest income
159.49%5.69M
55.36%1.47M
115.27%1.49M
268.94%1.46M
697.48%1.27M
1,625.98%2.19M
3,043.33%943K
2,470.37%694K
1,177.42%396K
307.69%159K
Non-operating interest expense
-73.41%459K
-85.76%44K
-89.28%46K
-64.52%171K
-60.87%198K
-39.59%1.73M
-44.82%309K
-43.70%429K
-36.83%482K
-34.46%506K
Other net income (expense)
98.05%-44K
86.79%-213K
15.68%-199K
410.73%637K
-33.83%-269K
-20.78%-2.26M
-757.98%-1.61M
72.90%-236K
71.00%-205K
-99.01%-201K
Gain on sale of security
213.64%25K
450.00%14K
128.57%6K
-66.67%1K
--4K
-540.00%-22K
---4K
-40.00%-21K
123.08%3K
----
Special income (charges)
96.91%-69K
85.89%-227K
4.65%-205K
405.77%636K
-35.82%-273K
-19.28%-2.23M
-733.68%-1.61M
74.88%-215K
70.03%-208K
-55.81%-201K
-Less：Restructuring and merger&acquisition
-96.91%69K
-85.89%227K
-4.65%205K
-405.77%-636K
35.82%273K
19.28%2.23M
733.68%1.61M
-74.88%215K
-70.03%208K
55.81%201K
Income before tax
-12.05%-72.85M
11.95%-19.31M
-14.44%-20.1M
-20.45%-17.09M
-44.32%-16.34M
14.74%-65.01M
-2.87%-21.93M
8.30%-17.57M
26.80%-14.19M
30.89%-11.32M
Income tax
0
0
0
0
0
4.44M
0
0
0
4.44M
Net income
-4.89%-72.85M
11.95%-19.31M
-14.44%-20.1M
-20.45%-17.09M
-3.64%-16.34M
8.91%-69.46M
-2.87%-21.93M
8.30%-17.57M
26.80%-14.19M
3.76%-15.77M
Net income continuous Operations
-4.89%-72.85M
11.95%-19.31M
-14.44%-20.1M
-20.45%-17.09M
-3.64%-16.34M
8.91%-69.46M
-2.87%-21.93M
8.30%-17.57M
26.80%-14.19M
3.76%-15.77M
Minority interest income
Net income attributable to the parent company
-4.89%-72.85M
11.95%-19.31M
-14.44%-20.1M
-20.45%-17.09M
-3.64%-16.34M
8.91%-69.46M
-2.87%-21.93M
8.30%-17.57M
26.80%-14.19M
3.76%-15.77M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-4.89%-72.85M
11.95%-19.31M
-14.44%-20.1M
-20.45%-17.09M
-3.64%-16.34M
21.42%-69.46M
-0.17%-21.93M
27.54%-17.57M
37.35%-14.19M
19.54%-15.77M
Basic earnings per share
4.35%-0.44
14.29%-0.12
0.00%-0.12
0.00%-0.1
9.09%-0.1
44.58%-0.46
6.67%-0.14
50.00%-0.12
56.52%-0.1
47.62%-0.11
Diluted earnings per share
4.35%-0.44
14.29%-0.12
0.00%-0.12
0.00%-0.1
9.09%-0.1
44.58%-0.46
6.67%-0.14
50.00%-0.12
56.52%-0.1
47.62%-0.11
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue -53.51%18.14M-65.65%2.15M-21.74%4.66M-67.34%4.65M-46.85%6.69M255.11%39.02M94.79%6.25M78.20%5.95M511.46%14.24M495.41%12.58M
Operating revenue -53.51%18.14M-65.65%2.15M-21.74%4.66M-67.34%4.65M-46.85%6.69M255.11%39.02M94.79%6.25M78.20%5.95M511.46%14.24M495.41%12.58M
Cost of revenue
Gross profit
Operating expense -5.93%96.18M-16.67%22.67M10.46%26.01M-15.88%23.67M2.03%23.83M23.72%102.24M14.23%27.2M12.71%23.55M38.79%28.14M32.24%23.35M
Selling and administrative expenses 26.02%22.48M20.05%5.1M67.25%5.84M15.00%5.98M13.49%5.55M4.07%17.83M-7.57%4.25M-16.50%3.49M16.12%5.2M26.15%4.89M
-General and administrative expense 26.02%22.48M20.05%5.1M67.25%5.84M15.00%5.98M13.49%5.55M4.07%17.83M-7.57%4.25M-16.50%3.49M16.12%5.2M26.15%4.89M
Research and development costs -12.69%73.7M-23.47%17.56M0.57%20.17M-22.88%17.69M-1.01%18.28M28.86%84.41M19.45%22.95M20.03%20.06M45.21%22.94M33.96%18.46M
Operating profit -23.43%-78.03M2.07%-20.52M-21.35%-21.35M-36.83%-19.02M-59.10%-17.14M11.76%-63.22M-1.70%-20.95M-0.25%-17.6M22.55%-13.9M30.71%-10.77M
Net non-operating interest income expense 1,022.10%5.23M124.13%1.42M446.42%1.45M1,600.00%1.29M408.36%1.07M117.07%466K219.62%634K136.05%265K88.25%-86K52.66%-347K
Non-operating interest income 159.49%5.69M55.36%1.47M115.27%1.49M268.94%1.46M697.48%1.27M1,625.98%2.19M3,043.33%943K2,470.37%694K1,177.42%396K307.69%159K
Non-operating interest expense -73.41%459K-85.76%44K-89.28%46K-64.52%171K-60.87%198K-39.59%1.73M-44.82%309K-43.70%429K-36.83%482K-34.46%506K
Other net income (expense) 98.05%-44K86.79%-213K15.68%-199K410.73%637K-33.83%-269K-20.78%-2.26M-757.98%-1.61M72.90%-236K71.00%-205K-99.01%-201K
Gain on sale of security 213.64%25K450.00%14K128.57%6K-66.67%1K--4K-540.00%-22K---4K-40.00%-21K123.08%3K----
Special income (charges) 96.91%-69K85.89%-227K4.65%-205K405.77%636K-35.82%-273K-19.28%-2.23M-733.68%-1.61M74.88%-215K70.03%-208K-55.81%-201K
-Less：Restructuring and merger&acquisition -96.91%69K-85.89%227K-4.65%205K-405.77%-636K35.82%273K19.28%2.23M733.68%1.61M-74.88%215K-70.03%208K55.81%201K
Income before tax -12.05%-72.85M11.95%-19.31M-14.44%-20.1M-20.45%-17.09M-44.32%-16.34M14.74%-65.01M-2.87%-21.93M8.30%-17.57M26.80%-14.19M30.89%-11.32M
Income tax 000004.44M0004.44M
Net income -4.89%-72.85M11.95%-19.31M-14.44%-20.1M-20.45%-17.09M-3.64%-16.34M8.91%-69.46M-2.87%-21.93M8.30%-17.57M26.80%-14.19M3.76%-15.77M
Net income continuous Operations -4.89%-72.85M11.95%-19.31M-14.44%-20.1M-20.45%-17.09M-3.64%-16.34M8.91%-69.46M-2.87%-21.93M8.30%-17.57M26.80%-14.19M3.76%-15.77M
Minority interest income
Net income attributable to the parent company -4.89%-72.85M11.95%-19.31M-14.44%-20.1M-20.45%-17.09M-3.64%-16.34M8.91%-69.46M-2.87%-21.93M8.30%-17.57M26.80%-14.19M3.76%-15.77M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -4.89%-72.85M11.95%-19.31M-14.44%-20.1M-20.45%-17.09M-3.64%-16.34M21.42%-69.46M-0.17%-21.93M27.54%-17.57M37.35%-14.19M19.54%-15.77M
Basic earnings per share 4.35%-0.4414.29%-0.120.00%-0.120.00%-0.19.09%-0.144.58%-0.466.67%-0.1450.00%-0.1256.52%-0.147.62%-0.11
Diluted earnings per share 4.35%-0.4414.29%-0.120.00%-0.120.00%-0.19.09%-0.144.58%-0.466.67%-0.1450.00%-0.1256.52%-0.147.62%-0.11
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg